These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5050852)

  • 21. Prevention of oxalate and phosphate lithiasis by alanine.
    Chow FH; Hamar DW; Udall RH
    Invest Urol; 1974 Jul; 12(1):50-3. PubMed ID: 4835490
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of penicillamine and allopurinol in the treatment of urinary lithiasis due to cystinuria and hyperuricemia].
    López-Engelking R
    Gac Med Mex; 1968 Aug; 98(8):1066-75. PubMed ID: 5722362
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of long-term pyridoxine administration on serum and urinary values of calculi-forming substances in Ca-oxalate urolithiasis].
    Revúsová V; Gratzlová J; Zvara V; Krídl J; Suchánek B
    Vnitr Lek; 1978 May; 24(5):445-50. PubMed ID: 96593
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of renal calculi.
    Coe FL; Favus MJ
    Adv Intern Med; 1980; 26():373-92. PubMed ID: 7013442
    [No Abstract]   [Full Text] [Related]  

  • 25. [Problems in the therapy of cystine urolithiasis using penicillamine].
    Revúsová V; Zvara V
    Bratisl Lek Listy; 1970 Mar; 53(3):333-6. PubMed ID: 5438749
    [No Abstract]   [Full Text] [Related]  

  • 26. Nutrition and urolithiasis.
    Smith LH; Van Den Berg CJ; Wilson DM
    N Engl J Med; 1978 Jan; 298(2):87-9. PubMed ID: 339082
    [No Abstract]   [Full Text] [Related]  

  • 27. [Litholysis of uric acid stones by peroral therapy (author's transl)].
    Tomasović D; Bencić K; Grims P
    Lijec Vjesn; 1979 Oct; 101(10):622-4. PubMed ID: 545019
    [No Abstract]   [Full Text] [Related]  

  • 28. Biochemical studies on bilharzial and nonbilharzial hyperoxaluria: effect of pyridoxine and allopurinol treatment.
    el-Habet AE; el-Sewedy SM; el-Sharaky A; Gaafar NK; Abdel-Rafee A; Hamoud F
    Biochem Med Metab Biol; 1987 Aug; 38(1):1-8. PubMed ID: 3663392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug dosage protocol for calcium oxalate stone.
    Marickar YM; Salim A
    Urol Res; 2009 Dec; 37(6):353-7. PubMed ID: 19826800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allopurinol treatment for calcium stone disease.
    Br Med J; 1977 Nov; 2(6098):1302-3. PubMed ID: 589161
    [No Abstract]   [Full Text] [Related]  

  • 31. Trace elements in kidney stones from three areas in the United States.
    Levinson AA; Nosal M; Davidman M; Prien EL; Prien EL; Stevenson RG
    Invest Urol; 1978 Jan; 15(4):270-4. PubMed ID: 627468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recurrent urolithiasis--analysis of its etiology and treatment].
    Murakami M; Yamaguchi K; Mori I; Naito H; Miyauchi T; Ito H; Shimazaki J
    Nihon Hinyokika Gakkai Zasshi; 1982 Nov; 73(11):1402-9. PubMed ID: 7154469
    [No Abstract]   [Full Text] [Related]  

  • 33. [Satisfactory prophylaxis of urinary lithiasis with D-penicillamine in cystinuria].
    Wenzl H; Mauermayer W
    Sem Hop; 1970 Apr; 46(17):1166-9. PubMed ID: 4315235
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prevention and medical treatment of cystine lithiasis].
    Tizzani A; Frea B; Borgno M
    Minerva Urol; 1976; 28(2-3):80-5. PubMed ID: 995106
    [No Abstract]   [Full Text] [Related]  

  • 35. [Medical treatment of cystine lithiasis in children].
    Laurenti C; De Dominicis C; Gallucci M; Iori F; Dal Forno S; Franco G
    J Urol (Paris); 1984; 90(2):117-21. PubMed ID: 6491345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [5-year clinical experience with the kidney calculi solvent Magurlit].
    Baranyai E; Kis E; Szebeni R
    Orv Hetil; 1979 Jul; 120(30):1823-4. PubMed ID: 382037
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapy and prevention of recurrence of urinary calculi].
    Bach D; Vahlensieck W
    Dtsch Med Wochenschr; 1980 May; 105(22):783-6. PubMed ID: 7408647
    [No Abstract]   [Full Text] [Related]  

  • 38. [Changes in the therapeutic indication position in relation to peroral litholysis of urinary calculi].
    Loebenstein H
    Urologe; 1966 Jul; 5(4):178-81. PubMed ID: 5995238
    [No Abstract]   [Full Text] [Related]  

  • 39. [Magnesium in the prevention of calcium oxalate urinary calculi].
    Rugendorff EW; Covaliu T
    Z Urol Nephrol; 1965 May; 58(5):341-4. PubMed ID: 5830879
    [No Abstract]   [Full Text] [Related]  

  • 40. [Color tests for the qualitative determination of cystine and uric acid in urinary calculi].
    Kleeberg J
    Urologe A; 1972 Nov; 11(6):321-3. PubMed ID: 4645821
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.